VitaNova Life Sciences (VNOV) Cash from Operations Growth (1y) (2018 - 2026)
VitaNova Life Sciences (VNOV) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Akso Health |
2,315,158.81 Bn |
2,315,158.63 Bn |
- |
- |
| 2 |
Mckesson |
92.76 Bn |
89.18 Bn |
4.04 Bn |
-55.85% |
| 3 |
Cencora |
52.82 Bn |
50.83 Bn |
3.59 Bn |
-60.06% |
| 4 |
Cardinal Health |
52.17 Bn |
48.39 Bn |
2.50 Bn |
-37.57% |
| 5 |
Henry Schein |
9.19 Bn |
9.71 Bn |
1.07 Bn |
-362.16% |
| 6 |
Accendra Health |
246.88 Mn |
-90.00 Mn |
312.39 Mn |
-42.81% |
| 7 |
Edap Tms |
161.92 Mn |
146.92 Mn |
8.15 Mn |
44.37% |
| 8 |
111 |
107.47 Mn |
25.61 Mn |
23.58 Mn |
164.21% |
| 9 |
Cosmos Health |
9.42 Mn |
7.26 Mn |
1.38 Mn |
-472.72% |
| 10 |
VitaNova Life Sciences |
- |
- |
316,343.00 |
-143.27% |
| Date | Value |
|---|
| Jan 31, 2026 |
-143.27% |
| Oct 31, 2025 |
2,327.64% |
| Jul 31, 2025 |
152.34% |
| Apr 30, 2025 |
350.61% |
| Jan 31, 2025 |
238.74% |
| Oct 31, 2024 |
209.62% |
| Jul 31, 2024 |
-1,827.57% |
| Apr 30, 2024 |
-8,266.96% |
| Jan 31, 2024 |
-434.33% |
| Oct 31, 2023 |
-250.60% |
| Jul 31, 2023 |
-485.59% |
| Apr 30, 2023 |
83.48% |
| Jan 31, 2023 |
-637.52% |
| Oct 31, 2022 |
-72.92% |
| Jul 31, 2022 |
197.68% |
| Jan 31, 2022 |
144.75% |
| Oct 31, 2021 |
164.09% |
| Jan 31, 2021 |
-62.37% |
| Oct 31, 2020 |
-161.67% |
| Apr 30, 2020 |
-8.43% |
